drugset
drugset / Trial / NCT00428129

Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT

NCT00428129 ↗

Phase 2 Terminated 6 enrolled ThromboGenics Bacchus Vascular · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

A single centre, single-arm study to evaluate safety and efficacy of microplasmin administration via the Trellis-8 Infusion System in patients with acute iliofemoral DVT

Timeline

Start
2007-03
Primary completion
2008-07
Completion
2008-10

Outcome

Outcome not reported

Stopped: “Sponsor's decision to not pursue uPLi for vascular conditions including DVT.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Ocriplasmin Protein / enzyme biologic 20 mg Other
Subject Ocriplasmin Protein / enzyme biologic 40 mg Other

Indications

venous thromboembolism